Inside the Bottle brings you the latest supplement industry news in this monthly roundup
If you are having trouble reading this email, read the online version
 
Inside the Bottle
 
image
 

10 key trends from Vitafoods Europe – article

Business strategist Greg Horn identified the top 10 trends that emerged from the massive global show, held for the first time in Barcelona. See what caught his eye regarding GLP-1, longevity and more and find out how the show compared to past events held in Geneva.

 
Are soft chews the new gummy? – article

Soft chew sales rose by 41% in 2024, according to SPINS. And these softer, creamier bites may be able to handle a higher active ingredient load than gummies. Innovation keeps both delivery modes dynamic. Find out how the battle for shelf space is shaking out.

 

  Supplement industry’s big opportunity lies in cost-effectively filling health care gaps – article

Incoming President of Sonoran University of Health Sciences Lise Alschuler, N.D., speaks about natural health care opportunities and transformative approaches for addressing public health challenges. Read the interview here.


 

Social media fuels botanical renaissance – article

The rise of wellness content creators and herbalist educators on TikTok, Instagram and YouTube has democratized knowledge about botanical wellness, making traditional plant wisdom accessible to millions of U.S. consumers. And according to NBJ research, it’s not only the youngest ones who are learning and buying online. Learn more.

 

 

 

NBJ ‘2025 Supplement Business Report’ preview – podcast

Herbs and botanicals, which took a dip in sales in 2022, are on the rebound. Younger shoppers are seeking in-person shopping experiences. The 2025 NBJ Supplement Business Report doesn’t publish until July, but you can get a preview of highlights like these on the latest episode of The Natural List podcast. Listen here.

Regulators mostly mum on GLP-1 claims – article

Though the number of dietary supplement brands making GLP-1-related claims is spiking, regulatory enforcement is scarce — so far. In fact, FDA has only issued one warning letter to a supplement company for GLP-1-related claims. Learn why experts think this is the case and which claims they believe are most risky.

 

 

 

Did you miss the 2025 Inside the Bottle Summit? Watch on demand! – webinar

Don’t miss this opportunity to build a roadmap for the future of your business. Dive into the critical data-driven orientation that is shaping the dietary supplement industry today. Learn about top industry trends from leading industry experts and hear how the supplement industry is transforming the way it approaches innovation, while maintaining integrity and its core vision for health.




 
 
ITB
  Inside the Bottle unites companies from across the supplement supply chain to advocate for a transparent, collaborative supplement industry that supports consumer health empowerment. #InsidetheBottle
 
 
image
 
image
 
 
 
By Informa Markets
 
 
This email was sent to you by the Informa Markets Division of Informa PLC (Privacy Policy).
Informa PLC's registered office is 5 Howick Place, London SW1P 1WG.
Registered in England and Wales. Number 8860726.
 
If you do not wish to receive further information from us, please click here.
Alternatively, to contact our data services team to have your details or preferences updated please email [email protected].